Changes in serum afamin and vitamin E levels after selective LDL apheresis
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Clinical Apheresis"
DOI: 10.1002/jca.21636
Abstract: Afamin is a plasma vitamin E‐binding glycoprotein partially associated with ApoA1‐containing high‐density lipoprotein (HDL) subfractions. In a previous study, the serum vitamin E decreased after low‐density lipoprotein (LDL) apheresis, while vitamin E/cholesterol ratio increased. We… read more here.
Keywords: ldl apheresis; changes serum; serum afamin; apheresis changes ... See more keywords
The fluctuation of skin perfusion pressure in hemodialysis patients treated with LDL apheresis therapy: A comparison of LDL adsorption and double filtration plasmapheresis.
Sign Up to like & getrecommendations! Published in 2022 at "Journal of clinical apheresis"
DOI: 10.1002/jca.22029
Abstract: BACKGROUND There have been a number of reports suggesting that LDL apheresis, including LDL adsorption and double filtration plasmapheresis (DFPP), can be applied for the treatment of lower extremity peripheral arterial disease (PAD) in hemodialysis… read more here.
Keywords: apheresis; ldl apheresis; dfpp; hemodialysis patients ... See more keywords
Liposorber® LA-15 system for LDL apheresis in resistant nephrotic syndrome patients
Sign Up to like & getrecommendations! Published in 2021 at "Pediatric Nephrology"
DOI: 10.1007/s00467-021-05211-8
Abstract: Steroid-resistant nephrotic syndrome (SRNS) is a major cause of stage 5 chronic kidney disease (CKD 5) in children. LDL apheresis (LDL-A) is now FDA approved for the treatment of pediatric focal segmental glomerulosclerosis (FSGS). Effective… read more here.
Keywords: ldl apheresis; treatment; resistant nephrotic; nephrotic syndrome ... See more keywords
Effects of LDL apheresis on proteinuria in patients with diabetes mellitus, severe proteinuria, and dyslipidemia
Sign Up to like & getrecommendations! Published in 2020 at "Clinical and Experimental Nephrology"
DOI: 10.1007/s10157-020-01959-9
Abstract: Background Patients with diabetes mellitus and severe proteinuria present with poor renal prognoses, despite improvements in diabetes and kidney disease therapies. In this study, we designed a low-density lipoprotein (LDL)-cholesterol apheresis treatment for patients with… read more here.
Keywords: patients diabetes; ldl apheresis; severe proteinuria; proteinuria dyslipidemia ... See more keywords
Impact of evolocumab treatment on low-density lipoprotein cholesterol levels in heterozygous familial hypercholesterolemic patients withdrawing from regular apheresis.
Sign Up to like & getrecommendations! Published in 2017 at "Atherosclerosis"
DOI: 10.1016/j.atherosclerosis.2017.09.011
Abstract: BACKGROUND AND AIMS Low-density lipoprotein (LDL) apheresis has been used to treat refractory hyperlipidemia such as familial hypercholesterolemia (FH). Evolocumab, a proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor used in clinical settings, can reduce LDL… read more here.
Keywords: ldl apheresis; density lipoprotein; low density; apheresis ... See more keywords
Efficacy of LDL apheresis for the treatment of cholesterol crystal embolism: A prospective, controlled study
Sign Up to like & getrecommendations! Published in 2021 at "Therapeutic Apheresis and Dialysis"
DOI: 10.1111/1744-9987.13706
Abstract: This study was performed to evaluate the efficacy and safety of LDL apheresis (LDL‐A) for the treatment of cholesterol crystal embolism (CCE) after cardiovascular procedures. We conducted a prospective multicenter study of 34 patients with… read more here.
Keywords: cholesterol crystal; study; apheresis; crystal embolism ... See more keywords
Plaque Regression and Endothelial Progenitor Cell Mobilization With Intensive Lipid Elimination Regimen (PREMIER)
Sign Up to like & getrecommendations! Published in 2020 at "Circulation: Cardiovascular Interventions"
DOI: 10.1161/circinterventions.119.008933
Abstract: Supplemental Digital Content is available in the text. Background: Low-density lipoproteins (LDLs) are removed by extracorporeal filtration during LDL apheresis. It is mainly used in familial hyperlipidemia. The PREMIER trial (Plaque Regression and Progenitor Cell… read more here.
Keywords: progenitor cell; mobilization; progenitor; plaque regression ... See more keywords